Hung-Ming Wang

6PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

|Dec 23, 2022
MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.

Tiing Yee Siow, Chih-Hua Yeh, Gigin Lin

|Aug 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.

Caroline Even, Hung-Ming Wang, Shau-Hsuan Li

|Jul 24, 2021
Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study.

Yung-Chih Chou, Kang-Hsing Fan, Chien-Yu Lin

|Jul 02, 2021
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.

Hsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui

|Jun 05, 2019
Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas.

Huei-Tzu Chien, Sou-De Cheng, Chun-Ta Liao

Pageof 1

Frequent Collaborators

1 joint publications

Huei-Tzu Chien

1 joint publications

Shiang-Fu Huang

1 joint publications

Chen-Yang Huang

1 joint publications

Yin-Kai Chao